ATE190501T1 - Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial - Google Patents

Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial

Info

Publication number
ATE190501T1
ATE190501T1 AT93914191T AT93914191T ATE190501T1 AT E190501 T1 ATE190501 T1 AT E190501T1 AT 93914191 T AT93914191 T AT 93914191T AT 93914191 T AT93914191 T AT 93914191T AT E190501 T1 ATE190501 T1 AT E190501T1
Authority
AT
Austria
Prior art keywords
cancer cell
providing
compound
cytotoxic compound
activation material
Prior art date
Application number
AT93914191T
Other languages
English (en)
Inventor
Jerzy Jankun
Richard Hart
Original Assignee
Univ Toledo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toledo filed Critical Univ Toledo
Application granted granted Critical
Publication of ATE190501T1 publication Critical patent/ATE190501T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT93914191T 1992-05-28 1993-05-27 Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial ATE190501T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88978392A 1992-05-28 1992-05-28
US5981393A 1993-05-10 1993-05-10
PCT/US1993/005034 WO1993024141A1 (en) 1992-05-28 1993-05-27 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material

Publications (1)

Publication Number Publication Date
ATE190501T1 true ATE190501T1 (de) 2000-04-15

Family

ID=26739215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914191T ATE190501T1 (de) 1992-05-28 1993-05-27 Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial

Country Status (6)

Country Link
EP (1) EP0643584B1 (de)
AT (1) ATE190501T1 (de)
AU (1) AU4394293A (de)
DE (1) DE69328092T2 (de)
ES (1) ES2143504T3 (de)
WO (1) WO1993024141A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024453A1 (en) * 1995-12-28 1997-07-10 Chiron Corporation Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells
US6277818B1 (en) 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
WO2005048822A2 (en) * 2003-11-18 2005-06-02 Attenuon Llc Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
US20070190068A1 (en) * 2005-10-10 2007-08-16 Richard Hart uPAR-binding molecule-drug conjugates and uses thereof
WO2008073312A2 (en) 2006-12-08 2008-06-19 Attenuon, Llc Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
US8877156B2 (en) 2007-06-26 2014-11-04 New York University Contrast agents anchored by thiols on nanoparticles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
DE69033653T2 (de) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 (Fonden Til Fremme Af Eksperimental Cancerforskning), Kopenhagen Plasminogen-aktivator-rezeptor vom urokinasetyp

Also Published As

Publication number Publication date
EP0643584A1 (de) 1995-03-22
ES2143504T3 (es) 2000-05-16
EP0643584B1 (de) 2000-03-15
AU4394293A (en) 1993-12-30
DE69328092D1 (de) 2000-04-20
EP0643584A4 (de) 1995-07-26
WO1993024141A1 (en) 1993-12-09
DE69328092T2 (de) 2000-07-20

Similar Documents

Publication Publication Date Title
EP0504327A4 (en) Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
IT1260656B (it) Articolo assorbente comprendente un materiale per il controllo dell'odore e relativo impiego.
HUT34348A (en) New process for producing immunotoxin conjugates
PH22075A (en) New complex compounds of piroxicam with cyclodextrin having antiinflammatory activity and pharmaceutical compositions containing them
ATE187491T1 (de) Isolierung, selektion und vermehrung von tierischen transgen-stammzellen
DE69414369D1 (de) Aerosol-spender und verfahren zu seiner herstellung
ATE47711T1 (de) Biologisch aktive verbindung mit anti-prolyl endopeptidasewirkung.
FR2685922B1 (fr) Buse coaxiale de traitement superficiel sous irradiation laser, avec apport de materiaux sous forme de poudre.
ES449284A1 (es) Perfeccionamientos introducidos en un tubo de envase.
DE69328092D1 (de) Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial
DE3173520D1 (en) Shampoo composition
ES2017557A6 (es) Procedimiento para la preparacion de granulos microencapsulados de eritromicina.
TR27789A (tr) Peroksijene-dayali oksitleme maddelerinin in situ kosullarinda üretilmesi.
ES2059520T3 (es) Articulos de material compuesto.
UA29392C2 (uk) Пакувальний контейнер
CA2228685A1 (en) A system for delivering hydrophobic liquid bleach activators
FR2506831A1 (fr) Procede de guidage d'une machine de forage en utilisant la radioactivite naturelle
DE59304544D1 (de) Abdichtung zwischen zwei ineinandersteckbaren betonfertigteilen
MX9303136A (es) Metodo de entrega de un compuesto citotoxico a una celula cancerosa, que usa una trayectoria de material activo biologicamente.
DE69321134D1 (de) Plasminogen-derivate die durch thrombin aktivierbar sind
TW336230B (en) Process for the production of olefinic unsaturated compounds
JPS57106637A (en) Acetylcycloundecane or acetylcycloundecene, perfume consisting thereof and perfume composition containing same
ES8204380A1 (es) Perfeccionamientos introducidos en los dispositivos de aco- plamiento para conectar una salida de material a un envase
MX9301438A (es) Composiciones que contienen combinaciones de agente tensioactivo y derivados de agente acilante succinico o compuestos hidroxiaromaticos y metodo para su uso.
ES1026043U (es) Trasportador en altura vibrante perfeccionado.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee